ENYO Pharma raises 40 mln pounds

ENYO Pharma said June 4 that it raised 40 million pounds ($53.5 million) in a series B round led by OrbiMed, followed by Andera Partners (previously EDRIP) and Bpifrance Large Venture as new shareholders. Existing shareholders, Sofinnova Private Capital VII, Morningside Venture Investments, InnoBio and Inserm Transfert Initiative also participated to this round. ENYO is a clinical stage biotech company.

North AmericaUSBriefs